Established in 1985, COC Farmaceutici is an Italian Contract Manufacturing (CMO) for medical devices and pharmaceutical products mainly in the ophthalmic market. COC Farmaceutici has a unique competitive positioning in the arena of the contract manufacturers, being among the few European CMOs dedicated to liquid and quasi-liquid formats. The Company is the one-stop-shop, from laboratory to shelf for its customers, who are mainly well-known Italian pharmaceutical groups.

Sector: Contract manufacturing services for pharmaceuticals and cosmetics

Investment Year: 2016

Investment type: leveraged management buy-in
Share: controlling
Revenue class (€M): >40 (30% exported)
Employees class: 100-250
Office: Carpi (MO)

Value creation: Aksìa Group acquired COC Farmaceutici from the founding families to support the next phase of growth in a market characterized by an outsourcing trend by pharmaceutical companies. The project envisages the hiring of a new management team, the re-design of the commercial strategy, the expansion of production capacity and the enhancement of R&D capabilities, which are distinct characteristics to further enlarge the customer base and increase the penetration in the private label market.